MEDIFAST INC (MED) — SEC Financial Statements & Analysis

MEDIFAST INC (MED) is a miscellaneous food preparations & kindred products company, incorporated in DE. MEDIFAST INC trades on NYSE as: MED. MEDIFAST INC (MED)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, MEDIFAST INC carries a market cap of $118.14M, a P/E ratio of -4.61x, a P/B ratio of 0.60x, a P/S ratio of 0.37x, an enterprise value of $46.23M, and an EV/EBITDA multiple of -8.17x. On profitability, it posts a gross margin of 69.24%, an operating margin of -6.15%, a net margin of -8.08%, a Return on Equity (ROE) of -12.42%, a Return on Assets (ROA) of -9.67%, and a Return on Invested Capital (ROIC) of -15.32%. Per share, it reports EPS of $-2.30, diluted EPS of $-2.30, free cash flow per share of $0.36, and a dividend per share of $0.02. Over the trailing year, it posted revenue growth of -34.03% year-over-year, net income growth of -803.93% year-over-year, and EPS growth of -794.83% year-over-year. On the balance sheet, it maintains a current ratio of 4.86x, a quick ratio of 4.21x, working capital of $160.47M, a debt-to-equity ratio of 0.33x, a debt ratio of 0.25, an interest coverage ratio of -5.99x, free cash flow of $4.01M (TTM), and net debt of $-71.91M. Figures sourced from SEC EDGAR.

Market Cap

$118.14M

P/E TTM

-4.61x

EPS TTM

$-2.30

P/B TTM

0.60x

ROE TTM

-12.42%

ROA TTM

-9.67%

Debt To Equity

0.33x

Free Cash Flow TTM

$4.01M

Net Revenue TTM Growth 1Y

-34.03%

Data as of 2026-06-30 · Source: SEC EDGAR